|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
OLC1935158104 |
| 003 |
DE-627 |
| 005 |
20230508083634.0 |
| 007 |
tu |
| 008 |
140123s2014 xx ||||| 00| ||und c |
| 028 |
5 |
2 |
|a sw140122_1
|
| 035 |
|
|
|a (DE-627)OLC1935158104
|
| 035 |
|
|
|a (DE-599)GBVOLC1935158104
|
| 035 |
|
|
|a (KEY)0047440120140200167000200210epitome2anopenlabelstudyassessingthetransitiontoan
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 082 |
0 |
4 |
|a 610
|
| 084 |
|
|
|a XA 18100
|q AVZ
|2 rvk
|
| 084 |
|
|
|a 44.85
|2 bkl
|
| 100 |
1 |
|
|a Sitbon, Olivier
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a EPITOME-2: An open-label study assessing the transition to a new formulation of intravenous epoprostenol in patients with pulmonary arterial hypertension
|
| 264 |
|
1 |
|c 2014
|
| 300 |
|
|
|a 8
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 700 |
1 |
|
|a Delcroix, Marion
|4 oth
|
| 700 |
1 |
|
|a Bergot, Emmanuel
|4 oth
|
| 700 |
1 |
|
|a Boonstra, Anco B.
|4 oth
|
| 700 |
1 |
|
|a Granton, John
|4 oth
|
| 700 |
1 |
|
|a Langleben, David
|4 oth
|
| 700 |
1 |
|
|a Subías, Pilar Escribano
|4 oth
|
| 700 |
1 |
|
|a Galiè, Nazzareno
|4 oth
|
| 700 |
1 |
|
|a Pfister, Thomas
|4 oth
|
| 700 |
1 |
|
|a Lemarié, Jean-Christophe
|4 oth
|
| 700 |
1 |
|
|a Simonneau, Gérald
|4 oth
|
| 773 |
0 |
8 |
|i Enthalten in
|t American heart journal
|d St. Louis, Mo. : Mosby, 1925
|g 167(2014), 2 vom: Feb., Seite 210-217
|w (DE-627)129268526
|w (DE-600)80026-0
|w (DE-576)014458942
|x 0002-8703
|7 nnns
|
| 773 |
1 |
8 |
|g volume:167
|g year:2014
|g number:2
|g month:02
|g pages:210-217
|g extent:8
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_OLC
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a SSG-OLC-DE-84
|
| 912 |
|
|
|a GBV_ILN_22
|
| 912 |
|
|
|a GBV_ILN_2012
|
| 912 |
|
|
|a GBV_ILN_4012
|
| 912 |
|
|
|a GBV_ILN_4125
|
| 912 |
|
|
|a GBV_ILN_4219
|
| 912 |
|
|
|a GBV_ILN_4305
|
| 936 |
r |
v |
|a XA 18100
|
| 936 |
b |
k |
|a 44.85
|q AVZ
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 167
|j 2014
|e 2
|c 2
|h 210-217
|g 8
|
